Showing results (231-240 of 295) with videos related to
Sort By:
Pageof 30
American Journal of Hematology|October 1, 1989
Platelet survival in patients with beta-thalassemiaA Eldor, Y Krausz, H Atlan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1985
Nuclear magnetic resonance imaging of liver hemangiomasR Sigal, A Lanir, H Atlan, et al.The Journal of Surgical Research|June 29, 1999
Prolongation of rat skin and cardiac allograft survival by low molecular weight heparinO M Shapira, H Rene, O Lider, et al.International Immunology|December 1, 1996
The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BIB Reizis, F Mor, M Eisenstein, et al.International Immunology|January 1, 1997
Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7B Reizis, M Eisenstein, J Bocková, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1987
T lymphocyte line-mediated experimental allergic encephalomyelitis--a pharmacologic model for testing of immunosuppressive agents for the treatment of autoimmune central nervous system diseaseM E Westarp, H Wekerle, A Ben-Nun, et al.Neurology|January 21, 2012
Antigen microarrays identify CNS-produced autoantibodies in RRMSF J Quintana, M F Farez, G Izquierdo, et al.Cancer Research|November 15, 1994
Abnormal expression of perlecan proteoglycan in metastatic melanomasI R Cohen, A D Murdoch, M F Naso, et al.Blood|August 1, 1987
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin speciesM Bar-Ner, A Eldor, L Wasserman, et al.The Journal of Clinical Investigation|March 1, 1989
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparinsO Lider, E Baharav, Y A Mekori, et al.Pageof 30